Brandes Investment Partners LP Raises Stock Holdings in LENSAR, Inc. (NASDAQ:LNSR)

Brandes Investment Partners LP increased its holdings in shares of LENSAR, Inc. (NASDAQ:LNSR) by 12.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 373,198 shares of the company’s stock after acquiring an additional 42,250 shares during the period. Brandes Investment Partners LP owned about 3.27% of LENSAR worth $1,644,000 at the end of the most recent quarter.

Separately, DCF Advisers LLC increased its stake in LENSAR by 1.4% in the second quarter. DCF Advisers LLC now owns 241,484 shares of the company’s stock worth $1,087,000 after purchasing an additional 3,250 shares during the period. 40.15% of the stock is owned by institutional investors and hedge funds.

LENSAR Trading Up 3.2 %

Shares of LNSR opened at $4.58 on Tuesday. The firm has a fifty day moving average price of $4.59 and a 200-day moving average price of $4.20. The firm has a market capitalization of $52.20 million, a P/E ratio of -2.90 and a beta of 0.64. LENSAR, Inc. has a 12-month low of $1.80 and a 12-month high of $5.60.

LENSAR (NASDAQ:LNSR) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.53) earnings per share (EPS) for the quarter. The company had revenue of $12.64 million during the quarter. LENSAR had a negative net margin of 27.83% and a negative return on equity of 30.69%.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.